Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Exploring the binding motif in genome wide for p53, Pygo2 and H3K4-Me3 in mouse (Pten/Smad4 KO) PS cell line

ABSTRACT: Exploring the binding motif in genome wide for p53, Pygo2 and H3K4-Me3 in mouse (Pten/Smad4 KO) PS cell line

PROVIDER: PRJNA805188 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17972650_1.fastq.gz	Fastqsanger.gz
	SRR17972650_2.fastq.gz	Fastqsanger.gz
	SRR17972651_1.fastq.gz	Fastqsanger.gz
	SRR17972651_2.fastq.gz	Fastqsanger.gz
	SRR17972652_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Exploring the binding motif in genome wide for p53, Pygo2 and H3K4-Me3 in mouse (Pten/Smad4 KO) PS cell line

Project description:Since our data support that Pygo2 function is p53 Wild type status dependent and the interaction of Pygo2 with H3K4-Me3 is needed for the c-Kit regulation by Pygo2, however, neither Pygo2 nor p53 bind at c-Kit promoter region. To find out the potential co-binding locia for Pygo2, p53 and H3K4-Me3, we performed a Cut&Run assay followed by Miseq Sequencing.

2022-12-23 | GSE196486 | GEO

H3K4 Me3 occupancy of Control and AMPK knockdown Hep3B cells

Project description:H3K4 Me3 occupancy of Control and AMPK knockdown Hep3B cells

2022-03-26 | GSE97189 | GEO

SMAD4-NFATc1 protein-protein interaction informed therapeutic vulnerability in SMAD4-deficient pancreatic cancer

Project description:Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by a median survival rate of approximately six months. While genetic profiling has uncovered common mutations in PDAC, developing targeted therapeutic strategies remains challenging. SMAD4 is frequently mutated or deleted in 30-55% of PDAC patients and correlates with poor survival rates. Such mutations frequently result in loss-of-function, thereby disrupting normal cell cycle regulation and contributing to tumorigenesis. Therefore, translating SMAD4 genotype into actionable targets are highly desired for therapeutic innovation in PDAC. In this study, we performed a SMAD4-focused oncogenic protein-protein interaction (oncoPPI) network mapping and revealed a direct physical interaction between SMAD4 and NFATc1. We found that SMAD4 interacts with NFATc1 in a TGF-independent and NFATc1 phosphorylation-dependent manner. Further, SMAD4 sequesters NFATc1 in cytoplasm and inhibits NFATc1 transcriptional activity. In PDAC cells, SMAD4-loss releases its inhibitory activity on NFATc1, activates NFATc1 transcriptional activity which drives STAT3 mRNA and protein upregulation. Pharmacological profiling identified multiple STAT3 inhibitors selectively inhibit the growth of SMAD4-loss PDAC cells. These results suggested a rewired SMAD4-NFATc1-STAT3 axis and targeting STAT3 as a potential therapeutic strategy in SMAD4-loss PDAC.

2026-02-02 | PXD067749 | Pride

Examination of H3k27-me3, H3k27-ac, and H3k9-me3 in recurrent MCF7 cells

Project description:These expeirments compare the chnages in h3K27-me3, H3k27-ac, and H3K9-me3 levels that occur in recurrent MCF7 cells.

2021-07-01 | GSE175753 | GEO

Methanococcus voltae PS strain:PS

Project description:Methanococcus voltae PS transcriptome - H25-1-PS

| PRJNA1387537 | ENA

Methanococcus voltae PS strain:PS

Project description:Methanococcus voltae PS transcriptome - H37-1-PS

| PRJNA1387618 | ENA

Methanococcus voltae PS strain:PS

Project description:Methanococcus voltae PS transcriptome - Low-1-PS